相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
Richard Markus et al.
ADVANCES IN THERAPY (2019)
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Sizheng Zhao et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study
Kim Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis
K. Papp et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis
Paolo Dapavo et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
Estimated cost efficacy of systemic treatments that are approved by the US Food and Drug Administration for the treatment of moderate to severe psoriasis
Logan S. D'Souza et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
分享论文
